DYSLIPIDEMIA AND ATHEROGENIC RISK IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：1
|
作者：
Radillo, H. A. [1 ]
Batun, J. A. [1 ]
Hernandez, E. [1 ]
机构：
[1] Hosp Alta Especialidad Dr Gustavo A Rovirosa Pere, Villahermosa, Mexico
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0455
引用
收藏
页码：1062 / 1062
页数：1
相关论文
共 50 条
  • [41] Cardiovascular risk profile in juvenile systemic lupus erythematosus patients
    Sousa, H.
    Martins, V
    Gonzaga, D.
    Matos, P.
    Guedes, M.
    [J]. ALLERGY, 2009, 64 : 383 - 383
  • [42] HEART FAILURE AND CARDIOVASCULAR RISK IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Kim, Chang
    Al-Kindi, Sadeer
    Oliveira, Guilherme
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1338 - 1338
  • [43] Risk factors for hospitalization in Mexican patients with systemic lupus erythematosus
    Garcia-Canas, Iveth Eunice
    Cuevas-Orta, Enrique
    Herrera-Van Oostdam, David Alejandro
    Abud-Mendoza, Carlos
    [J]. LUPUS, 2024, 33 (08) : 892 - 898
  • [44] Underrecognition of cardiovascular risk factors in patients with systemic lupus erythematosus
    Elliott, JR
    Salerno, A
    Kao, A
    Vogt, M
    Edmundowicz, D
    Manzi, S
    [J]. CIRCULATION, 2006, 113 (08) : E329 - E329
  • [45] Risk factors for infectious complication in patients with systemic lupus erythematosus
    Aotsuka, S
    [J]. INTERNAL MEDICINE, 1996, 35 (08) : 593 - 594
  • [46] Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide
    Yilmaz, N.
    Emmungil, H.
    Gucenmez, S.
    Ozen, G.
    Yildiz, F.
    Balkarli, A.
    Kimyon, G.
    Coskun, B. N.
    Dogan, I.
    Pamuk, O. N.
    Yasar, S.
    Cetin, G. Yildirim
    Yazici, A.
    Esmen, S. Ergulu
    Cagatay, Y.
    Yilmaz, S.
    Celle, A.
    Cefle, A.
    Sayarhoglu, M.
    Kasifoglu, T.
    Karadag, O.
    Pehlivan, Y.
    Dalilic, E.
    Kisacik, B.
    Cobankara, V.
    Erken, E.
    Direskeneli, H.
    Aksu, K.
    Yavuz, S.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S67 - S67
  • [47] Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus
    Choi, May Y.
    Guan, Hongshu
    Yoshida, Kazuki
    Paudel, Misti
    Kargere, Benjamin A.
    Li, Daniel
    Ellrodt, Jack
    Stevens, Emma
    Cai, Tianrun
    Weber, Brittany N.
    Everett, Brendan M.
    Costenbader, Karen H.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 67
  • [48] Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopaenic purpura
    Xie, Wenhui
    Zhang, Zhuoli
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05)
  • [49] ASSESSMENT OF CARDIOVASCULAR RISK IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    McElhone, K.
    Smith, P. J.
    Teh, L-S
    [J]. RHEUMATOLOGY, 2003, 42 : 76 - 77
  • [50] Prevalence and risk factors of atherosclerosis in patients with systemic lupus erythematosus
    Stenina, OA
    Sorokin, EV
    Fomicheva, OA
    Karpov, YA
    Popkova, TV
    Reshetnyak, TM
    Nasonov, EL
    [J]. KARDIOLOGIYA, 2005, 45 (11) : 105 - 108
12345